Fri, Aug 1, 2014, 10:43 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • james9070 james9070 May 15, 2013 11:42 AM Flag

    I can't believe the way this stock keeps going up... and what exactly are the company's earnings to date?

    the only thing worse than not getting in on this rocket ride early was shorting it-- and I pity the poor fool who did that.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • system_architect_enterprise system_architect_enterprise May 15, 2013 10:24 PM Flag

      The earnings are starting to come in, but the real story is about the long term picture, which is shaping up nicely. Look at the potential. Based on the stated $300K/patient/year and 10K patients in the U.S. & EU; that is $3B/year & with 25M shares out, it equates to $120/share in revenue.

      @ P/E of 10 = $1,200/share
      @ P/E of 10 = $2,400/share

      That's if they get the whole available market. If they get just 10% then market value is still at $120-$240/share.

      This medicine is for patients who are dying, so it isn't elective like weight loss drugs, or other medications. With a potential of $1,200-$2,400/share in the long term, and $120-$240 in the short term, this is still a compelling buy.

33.22-0.39(-1.16%)Aug 1 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
NYSEFri, Aug 1, 2014 4:00 PM EDT
Bally Technologies, Inc.
NYSEFri, Aug 1, 2014 4:03 PM EDT
Durata Therapeutics, Inc.
NasdaqGMFri, Aug 1, 2014 4:00 PM EDT